Activating mutations of the CASR gene give rise to hypercalciuria and hypocalcemia because of the direct effect in TALH cells (where the CaSR can inhibit calcium absorption) and to the inhibition of PTH secretion, which induces additional downregulation of calcium absorption in the distal tubule. The gene discussed is PTH; the disease is Hypocalcemia.